Direct-to-consumer advertising of OTC agents under current FTC regulations: Concerns and comment

Headache

Volumn 41, Issue 6, 2001, Pages 534-536

  Sheftell, Fred ^a,b,c   Dodick, David ^a,b,c   Cady, Roger ^a,b,c  

^a NEW ENGLAND CENTER FOR HEADACHE   (United States)

^b MAYO CLINIC   (United States)

^c HEADACHE CARE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; EXCEDRIN; IBUPROFEN; NAPROXEN; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; ROFECOXIB;

CLINICAL PRACTICE; CONSUMER; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG INFORMATION; DRUG MARKETING; DRUG MISUSE; DRUG SAFETY; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; LAW; NEPHROTOXICITY; PRESCRIPTION; PRIORITY JOURNAL; SHORT SURVEY;

ADVERTISING; ANALGESICS; CONSUMER PARTICIPATION; DRUGS, NON-PRESCRIPTION; HEADACHE; HUMANS; UNITED STATES; UNITED STATES FEDERAL TRADE COMMISSION;

EID: 0034930247     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.2001.041006534.x     Document Type: Short Survey

References (16)

1. Pharmacology of over-the-counter analgesics used for the treatment of headache
2. Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal anti-inflammatory drugs
3. COX-2-selective NSAIDs: Biology, promises, and concerns
4. Prevalence of frequent headache in a population sample
5. Classification of daily and near-daily headaches: Field trial of revised IHS criteria
6. Drug overuse among patients with headache
7. Changing perspectives on chronic headache
8. Paradoxical effects of frequent analgesic use
9. Drug-induced refractory headache - Clinical features and management
10. Analgesic rebound headache: Theoretical and practical implications
11. Chronic daily headache
12. Effect of chronic analgesic exposure on the central serotonin system: A possible mechanism of analgesic abuse headache
13. Role and impact of over-the-counter medications in the management of headache